Citations

Clear

10 citation(s) found for "Stanley, Michael".

Update on Novel Biologic Therapies for Crohn Disease and the Impact of Imaging on Clinical Decision Making
Patel, Richa , Keyashian, Kian , Nazarian, Matthew , Dillman, Jonathan R. , Deepak, Parakkal , Fletcher, Joel G. , Fidler, Jeff L. , Anupindi, Sudha A. , Dane, Bari, Gee, Michael S. , Nazarian, Matthew , Patel, Richa D , Dane, Bari , Fletcher, Joel G , Deepak, Parakkal , Dillman, Jonathan R , Fidler, Jeff L. , Gee, Michael Stanley

Mayo Clinic

RadioGraphics | May 28, 2026 | Volume: 46 | Issue: 6 | Pages: No page available

10.1148/rg.250162 | PMID 42207683 Get It

Due to increasingly nuanced Crohn disease therapy selection and disease evaluation, radiologic assessment of transmural healing, although aspirational, may be more complete than endoscopic assessment of mucosal healing, which is the current treatment target.
Treatment of Children and Adults With X-Linked Hypophosphatemia With Calcitriol Alone: A Prospective, Open-Label Study
Jordan, Mackenzie, Gehman, Sarah, Rudolph, Sara , Jüppner, Harald , Thacher, Thomas, Lee, Hang , Gee, Michael S. , Pierce, Theodore T. , Ceglia, Lisa, Bouxsein, Mary , Demay, Marie B. , Liu, Eva S. , Lee, Hang , Ceglia, Lisa , Liu, Eva S , Mitchell, Deborah M. , Misra, Madhusmita , Thacher, Thomas, Gee, Michael Stanley

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 23, 2025 | Volume: 111 | Issue: 4 | Pages: e1037-e1049

10.1210/clinem/dgaf585 | PMID 41137448 Get It

Abstract Context Preclinical studies demonstrate that treatment with calcitriol attenuates skeletal complications in mice with X-linked hypophosphatemia (XLH). Objective This work aimed to assess serum markers of mineral metabolism, nephrocalcinosis, skeletal microarchitecture, growth, and evidence of rickets following calcitriol monotherapy in children and adults with XLH. Methods A 1-year, prospective, single-arm, open-label study was conducted comparing baseline and 12-month outcomes. Participants were recruited from outpatient endocrinology clinics in the United States. Data were collected in a research unit. Eligible participants were aged 4 years or older, not pregnant, with baseline 25-hydroxyvitamin D of 20 ng/mL or greater and normal serum calcium. Participants were treated with calcitriol, with dose based on serum and urinary calcium concentrations, for 1 year. The primary end points were change in serum phosphate and nephrocalcinosis (all participants) and rickets severity score (children). Secondary end points included changes in additional markers of mineral metabolism, skeletal microarchitecture parameters via high-resolution peripheral quantitative computed tomography (all participants), and height z-scores (children). Results Serum phosphate did not change over 12 months of optimized calcitriol treatment. Rickets improved in 2 of 4 children with open epiphyses; height z-scores were unchanged. Nephrocalcinosis scores remained stable. Adults had increased cortical thickness at the radius diaphysis (P = .012). Serum alkaline phosphatase decreased in children (P = .021) and parathyroid hormone trended lower both in children (P = .065) and adults (P = .063). Four participants developed mild hypercalcemia and 2 developed hypercalciuria that resolved with calcitriol titration. Conclusion Calcitriol monotherapy is safe and well-tolerated in XLH, with modest benefits on laboratory indices of mineral metabolism and rickets.
NeurAnki: Behind The Scenes of Creating the First-Ever Flashcard Based Deck for Resident Education (P12-5.009)
Albin, Casey, Saylor, Deanna , Stanley, Michael , Buletko, Andrew , Budhu, Joshua , Etter, Micah, Guduru, Zain , Kentris, Michael, Cheng‐Ching, Esteban , Budhu, Joshua A , Saylor, Deana , Marawar, Rohit , Christy, Alison , Riggins, Nina , Coon, Elizabeth A. , Roberts, Matthew, Antonio‐Santos, Aileen A.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208902 Get It

P0238 Reliability of magnetic resonance imaging indices for evaluating perianal fistulizing disease activity in paediatric Crohn’s disease
Karpewycz, John , Watson, Tom A. , Schneider, R, Alsabban, Zehour , Cytter-Kuint, Ruth, Lewindon, Peter , Gee, Michael S. , Hyams, J S, Allmen, Daniel von, Overstraeten, Anthony de Buck van , Shackelton, L, Rémillard, J, Ashton, H A, Taylor, Stuart A. , Church, Peter, Feagan, B, Griffiths, A, Crowley, Eileen , Rimola, Jordi , Schneider, R, Ma, Christopher , Zou, Guangyong , Gee, Michael Stanley , Rosen, Michael J. , Ashton, H, Dillman, Jonathan R , Fletcher, Joel G. , Church, Peter , Jairath, Vipul , Greer, Mary‐Louise C.

Mayo Clinic

Journal of Crohn's and Colitis | January 22, 2025 | Volume: 19 | Issue: Supplement_1 | Pages: i660-i661

10.1093/ecco-jcc/jjae190.0412 Get It

Abstract Background Progress in clinical trials and drug development for paediatric perianal fistulising CD (pfCD) depends upon accurate, reproducible imaging to assess disease activity and measure treatment response. We evaluated the inter- and intra-rater reliability of existing radiologic disease activity indices and anatomical classification systems previously identified as appropriate for assessment of paediatric pfCD.1 Methods A retrospective cohort (N=50) of magnetic resonance imaging (MRI) exams representing a full spectrum of paediatric (<18 years) perianal CD severity was selected by a single expert paediatric radiologist. Methods described by Zou2 were used to estimate sample size. Three separate radiologists (2 paediatric) blinded to clinical information assessed pfCD in the exams using the Magnetic Resonance Novel Index for Fistula Imaging in CD (MAGNIFI-CD), Van Assche Index (VAI), modified VAI (mVAI), Paediatric MRI based Perianal Crohn’s disease (PEMPAC) index, a visual analogue scale (VAS) of overall pfCD disease severity (range, 0-100 mm), as well as with the Park’s and St. James University Hospital anatomic classification systems. Two radiologists read all exams twice, separated by 2 weeks, and 1 radiologist read the exams once (250 total reads). Intra- and inter-rater reliability was evaluated using intraclass correlation coefficients (ICC; equivalent to weighted kappa). Precision of the ICC estimates was quantified with 95% confidence intervals (CIs) obtained using clustered bootstrapping. Degree of reliability was interpreted with benchmarks proposed by Landis and Koch3. Results Median age of children was 13.5 years (IQR 11.4-16.1), and 64% were male. Median Paediatric Crohn’s Disease Activity Index score at time of imaging was 17.5 (IQR 10-32.5). Substantial (ICC>0.61) inter-rater reliability was observed for MAGNIFI-CD, VAI, and mVAI (Table 1), with the highest ICCs observed for the mVAI (0.72 [0.6 to 0.79]). Moderate (ICC>0.41) inter-rater reliability was observed for PEMPAC, St. James University Hospital classification, and the VAS, and fair (ICC>0.21) inter-rater reliability was observed for Parks classification. Intra-rater reliability was nearly perfect (ICC>0.81) for the VAS, and substantial for all indices except for Parks classification, which had moderate (0.60 [0.44 to 0.75]) intra-rater reliability (Table 1). Conclusion Most existing multi-item MRI-based disease activity indices and the St. James Hospital classification were reliable for the assessment of paediatric pfCD in our cohort. Our preliminary results suggest that the disease activity indices may have utility to measure treatment effect in paediatric pfCD clinical trials. References 1.Crowley E, Ma C, Guizzetti L, Zou G, Lewindon PJ, Gee MS, et al. Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials. Inflamm Bowel Dis. 2024;30(3):357-69. 2.Zou GY. Sample size formulas for estimating intraclass correlation coefficients with precision and assurance. Statistics in Medicine. 2012;31(29):3972-398 3.Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74.
The Role of Imaging for Gastrointestinal Bleeding: Consensus Recommendations From the American College of Gastroenterology and Society of Abdominal Radiology
Sengupta, Neil , Bruining, David H. , Latorre, Melissa, Leighton, Jonathan A. , Wells, Michael , Guglielmo, Flavius F. , Gee, Michael S. , Yoo, Don C. , Ramalingam, Vijay , Huete, Álvaro , Sokhandon, Farnoosh , Grand, David , Tse, Justin R. , Fidler, Jeff L. , Guglielmo, Flavius F , Kastenberg, David , Brook, Olga R. , Naringrekar, Haresh , Gee, Michael Stanley , Soto, Jorge A. , Park, Seong Ho , Khandelwal, Ashish , Gupta, Avneesh , Allen, Brian C. , Anderson, Mark , Dane, Bari , Fidler, Jeff L.

Mayo Clinic

American Journal of Gastroenterology | March 5, 2024 | Volume: 119 | Issue: 3 | Pages: 438-449

10.14309/ajg.0000000000002631 | PMID 38857483 Get It

Gastrointestinal (GI) bleeding is the most common GI diagnosis leading to hospitalization within the United States. Prompt diagnosis and treatment of GI bleeding is critical to improving patient outcomes and reducing high healthcare utilization and costs. Radiologic techniques including computed tomography angiography, catheter angiography, computed tomography enterography, magnetic resonance enterography, nuclear medicine red blood cell scan, and technetium-99m pertechnetate scintigraphy (Meckel scan) are frequently used to evaluate patients with GI bleeding and are complementary to GI endoscopy. However, multiple management guidelines exist which differ in the recommended utilization of these radiologic examinations. This variability can lead to confusion as to how these tests should be used in the evaluation of GI bleeding. In this document, a panel of experts from the American College of Gastroenterology and Society of Abdominal Radiology provide a review of the radiologic examinations used to evaluate for GI bleeding including nomenclature, technique, performance, advantages, and limitations. A comparison of advantages and limitations relative to endoscopic examinations is also included. Finally, consensus statements and recommendations on technical parameters and utilization of radiologic techniques for GI bleeding are provided.
Institutional Variability in Anesthesia Time for Mehta Casting in Early-Onset Scoliosis (EOS)
Bonsignore-Opp, Lisa , Malka, Matan , Simhon, Matthew E. , Matsumoto, Hiroko , Sturm, Peter, Vitale, Michael G. , Group, On behalf of Pediatric Spine Study, Ball, Jacob R. , Pahys, Joshua M. , Larson, A. Noelle , Roye, Benjamin D. , Group, On behalf of Pediatric Spine Study

Mayo Clinic

Journal of Pediatric Orthopaedics | February 14, 2024 | Volume: 44 | Issue: 5 | Pages: 297-302

10.1097/bpo.0000000000002644 | PMID 38353100 Get It

Purpose: Mehta casting is a potentially curative intervention for early-onset scoliosis (EOS) that typically requires multiple anesthetics. The Food and Drug Administration (FDA) reported that >3 hours of anesthesia under the age of 3 years old may alter brain development; however, no standard exists for the duration of anesthesia during casting. The purpose of this study is to quantify the variability in anesthesia during Mehta casting. We hypothesize that significant institutional variability exists and may be attributed to modifiable factors. Methods: An EOS registry was used to identify patients who underwent at least one Mehta casting procedure. Anesthesia exposure was quantified, and site variability was assessed by patient characteristics, cast placement, procedure type, and equipment used. Results: Our cohort consisted of 208 patients from 5 institutions (age 2.6±1.4 y). There were 1097 Mehta casting procedures, with 5.4±3.6 castings per patient. Of these patients, 106 (51%) were female, with an average age of 2.11±1.29 years old at the time casting was initiated. Patient etiologies included 154 idiopathic (74.0%), 22 syndromic (10.6%), 18 congenital (8.7%), 11 neuromuscular (5.3%), and 3 unknown (1.4%). Anesthesia time was 69±31 minutes and varied significantly between sites (59±14 to 117±46 min; P<0.001). Cumulative anesthesia time for patients under 3 years was 320±197 minutes with 120/161 (74.5%) patients exceeding 3 hours. Anesthesia time was lower after the FDA warning in 2016 compared with pre-2016 (71±30 vs. 66±32, P=0.008). Conclusions: Patients undergoing Mehta casting are at significant risk of exceeding 3 hours of anesthesia, which the FDA has stated may be harmful for children <3 years. Significant site variability indicates that standardization protocols should be developed to encourage best practices and minimize anesthetic times. Level of Evidence: Prognostic Level II.
In-hospital outcomes of septal myectomy vs. alcohol septal ablation for hypertrophic cardiomyopathy with outflow tract obstruction: An update and insights from the national inpatient sample from 2011 to 2019
Inestroza, Karla , Mijares-Rojas, Ivan, Matute-Martínez, Carlos , Ergui, Ian , Vergara‐Sanchez, Carlos , Dangl, Michael , Hernandez, Rafael Jaciel, Vincent, Louis , Colombo, Rosario , Vergara-Sanchez, Carlos, Vergara Sanchez, Carlos A , Mijares-Rojas, Ivan A , Albosta, Michael Stanley , Hernandez, Rafael Jaciel , Ebner, Bertrand , Maning, Jennifer , Alfonso, Carlos

Mayo Clinic

Journal of Investigative Medicine | January 7, 2024 | Volume: 72 | Issue: 3 | Pages: 262-269

10.1177/10815589241226959 | PMID 38185664 Get It

Septal Myectomy (SM) and Alcohol Septal Ablation (ASA) improve symptoms in patients with Hypertrophic Cardiomyopathy with outflow tract obstruction (oHCM). However, outcomes data in this population is predominantly from specialized centers. The National Inpatient Database was queried from 2011 to 2019 for relevant international classification of diseases (ICD)-9 and -10 diagnostic and procedural codes. We compared baseline characteristics and in-hospital outcomes of patients with oHCM who underwent SM vs ASA. A p-value < 0.001 was considered statistically significant. We identified 15,119 patients with oHCM who underwent septal reduction therapies, of whom 57.4% underwent SM, and 42.6% underwent ASA. Patients who underwent SM had higher all-cause mortality (OR: 1.8 (1.3–2.5)), post-procedure ischemic stroke (OR: 2.3 (1.7–3.2)), acute kidney injury (OR: 1.4 (1.2–1.7)), vascular complications (OR: 3.6 (2.3–5.3)), ventricular septal defect (OR: 4.4 (3.2–6.1)), cardiogenic shock (OR: 1.7 (1.3–2.3)), sepsis (OR: 3.2 (1.9–5.4)), and left bundle branch block (OR: 3.5 (3–4)), compared to ASA. Patients who underwent ASA had higher post-procedure complete heart block (OR: 1.3 (1.1–1.4)), right bundle branch block (OR: 6.3 (5–7.7)), ventricular tachycardia (OR: 2.2 (1.9–2.6)), supraventricular tachycardia (OR: 1.6 (1.4–2)), and more commonly required pacemaker insertion (OR: 1.4 (1.3–1.7)) (p < 0.001 for all) compared to SM. This nationwide analysis evidenced that patients undergoing SM had higher in-hospital mortality and periprocedural complications than ASA; however, those undergoing ASA had more post-procedure conduction abnormalities and pacemaker implantation. The implications of these findings warrant further investigation regarding patient selection strategies for these therapies.
Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn’s Disease Clinical Trials
Crowley, Eileen , Ma, Christopher , Guizzetti, Leonard, Lewindon, Peter , Gee, Michael S. , Hyams, Jeffrey S. , Rosen, Michael J. , Allmen, Daniel von, Overstraeten, Anthony de Buck van , Shackelton, Lisa M. , Rémillard, Julie, Schleicher, Lauren S., Rimola, Jordi , Taylor, Stuart A. , Church, Peter , Feagan, Brian G. , Jairath, Vipul , Jairath, Vipul , Jairath, Vipul , Hyams, Jeffrey S , Shackelton, Lisa M , Rimola, Jordi , Ma, C , Jairath, V , Jairath, V , Jairath, Vipul , Zou, Guangyong , Gee, Michael Stanley , Dillman, Jonathan R , Fletcher, Joel G. , Griffiths, Anne Marie , Greer, Mary‐Louise C.

Mayo Clinic

Inflammatory Bowel Diseases | July 31, 2023 | Volume: 30 | Issue: 3 | Pages: 357-369

10.1093/ibd/izad134 | PMID 37524088 Get It

Abstract Background Perianal fistulas and abscesses occur commonly as complications of pediatric Crohn’s disease (CD). A validated imaging assessment tool for quantification of perianal disease severity and activity is needed to evaluate treatment response. We aimed to identify magnetic resonance imaging (MRI)-based measures of perianal fistulizing disease activity and study design features appropriate for pediatric patients. Methods Seventy-nine statements relevant to MRI-based assessment of pediatric perianal fistulizing CD activity and clinical trial design were generated from literature review and expert opinion. Statement appropriateness was rated by a panel (N = 15) of gastroenterologists, radiologists, and surgeons using modified RAND/University of California Los Angeles appropriateness methodology. Results The modified Van Assche Index (mVAI) and the Magnetic Resonance Novel Index for Fistula Imaging in CD (MAGNIFI-CD) were considered appropriate instruments for use in pediatric perianal fistulizing disease clinical trials. Although there was concern regarding the use of intravascular contrast material in pediatric patients, its use in clinical trials was considered appropriate. A clinically evident fistula tract and radiologic disease defined as at least 1 fistula or abscess on pelvic MRI were considered appropriate trial inclusion criteria. A coprimary clinical and radiologic end point and inclusion of a patient-reported outcome were also considered appropriate. Conclusion Outcomes of treatment of perianal fistulizing disease in children must include MRI. Existing multi-item measures, specifically the mVAI and MAGNIFI-CD, can be adapted and used for children. Further research to assess the operating properties of the indices when used in a pediatric patient population is ongoing.
Best Practice Guidelines for Surgical Site Infection in High-risk Pediatric Spine Surgery: Definition, Prevention, Diagnosis, and Treatment
Badin, Daniel , Leland, Christopher R. , Matsumoto, Hiroko , Vitale, Michael G. , Flynn, John M. , Samdani, Amer F. , Glotzbecker, Michael, Bachmann, Keith , Betz, Randal R. , Miyanji, Firoz , Shah, Suken A. , Sturm, Peter, Hwang, Steven W. , Upasani, Vidyadhar V. , Sucato, Daniel J. , Roye, Benjamin D. , Larson, A. Noelle , Yaszay, Burt , Pahys, Joshua M. , Newton, Peter O. , Erickson, Mark A. , Cahill, Patrick J. , Fletcher, Nicholas D , Sponseller, Paul D.

Mayo Clinic

Journal of Pediatric Orthopaedics | August 29, 2022 | Volume: 42 | Issue: 10 | Pages: e1008-e1017

10.1097/bpo.0000000000002255 | PMID 36037438 Get It

Background: Prior “best practice guidelines” (BPG) have identified strategies to reduce the risk of acute deep surgical site infection (SSI), but there still exists large variability in practice. Further, there is still no consensus on which patients are “high risk” for SSI and how SSI should be diagnosed or treated in pediatric spine surgery. We sought to develop an updated, consensus-based BPG informed by available literature and expert opinion on defining high-SSI risk in pediatric spine surgery and on prevention, diagnosis, and treatment of SSI in this high-risk population. Materials and Methods: After a systematic review of the literature, an expert panel of 21 pediatric spine surgeons was selected from the Harms Study Group based on extensive experience in the field of pediatric spine surgery. Using the Delphi process and iterative survey rounds, the expert panel was surveyed for current practices, presented with the systematic review, given the opportunity to voice opinions through a live discussion session and asked to vote regarding preferences privately. Two survey rounds were conducted electronically, after which a live conference was held to present and discuss results. A final electronic survey was then conducted for final voting. Agreement ≥70% was considered consensus. Items near consensus were revised if feasible to achieve consensus in subsequent surveys. Results: Consensus was reached for 17 items for defining high-SSI risk, 17 items for preventing, 6 for diagnosing, and 9 for treating SSI in this high-risk population. After final voting, all 21 experts agreed to the publication and implementation of these items in their practice. Conclusions: We present a set of updated consensus-based BPGs for defining high-risk and preventing, diagnosing, and treating SSI in high-risk pediatric spine surgery. We believe that this BPG can limit variability in practice and decrease the incidence of SSI in pediatric spine surgery. Level of Evidence: Not applicable.
What Are the Indications for Spinal Fusion Surgery in Scheuermann Kyphosis?
Polly, David W. , Ledonio, Charles Gerald T., Diamond, Beverly, Labelle, Hubert , Sucato, Daniel J. , Hresko, M. Timothy , Emans, John B. , Vitale, Michael G. , Erickson, Mark A. , Larson, A. Noelle , Polly, David

Mayo Clinic

Journal of Pediatric Orthopaedics | February 11, 2017 | Volume: 39 | Issue: 5 | Pages: 217-221

10.1097/bpo.0000000000000931 | PMID 30969249 Get It

Background: Surgical indications for Scheuermann kyphosis are variable. We sought to evaluate the characteristics of patients undergoing operative versus nonoperative treatment of Scheuermann kyphosis to better understand current practices and the factors which contribute to the decision for surgical management. Methods: Multicenter prospective cohort study. We evaluated consecutive patients presenting with Scheuermann kyphosis. Patients underwent either surgical or nonoperative management according to surgeon and patient discretion. Preoperative patient-reported outcome measures (Scoliosis Research Society and Spinal Appearance Questionnaire scores), demographics, and radiographic characteristics were assessed. Results: Overall, 150 patients with Scheuermann kyphosis were enrolled, with 77 choosing nonoperative treatment and 73 treated operatively. Compared with the nonoperative cohort, patients treated operatively were older (16.3±2.0 vs. 15.1±2.2, P=0.0004), and had higher body mass index (26.3±7.2 vs. 22.7±6.5, P=0.003), had greater T2-T12 kyphosis (71±14 degrees vs. 61±12 degrees, P<0.001), increased pelvic incidence (46 vs. 41 degrees, P=0.03) and pelvic tilt (10 vs. 3 degrees, P=0.03). There was no detected difference in maximal sagittal Cobb angle in the operative versus nonoperative patients (73±11 vs. 70±12 degrees, P=0.11). Functionally, the operative patients had worse Scoliosis Research Society pain scores (3.7±0.9 vs. 4.1±0.7, P=0.0027) and appearance scores (2.9±0.7 vs. 3.4±0.8, P <0.0001). Conclusions: Patients undergoing surgical management of Scheuermann disease were more likely to have large body mass index and worse pain scores. Other factors beyond radiographic measurement likely contribute to the decision for surgical management of Scheuermann kyphosis. Level of Evidence: Level II.